Selected research
Market Analysis & Forecast
Global Gliquidone Market Analysis and Forecast 2026-2032
Market perspective
The global Gliquidone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Gliquidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Gliquidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Gliquidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Gliquidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Gliquidone include Boehringer Ingelheim, Dexa Medica, Menarini Belgium, CR Double-Crane, Jinheng Pharma, Vanguard Pharma, Yiling Pharma and TIPR, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Gliquidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Gliquidone, also provides the sales of main regions and countries. Of the upcoming market potential for Gliquidone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gliquidone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gliquidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gliquidone sales, projected growth trends, production technology, application and end-user industry.
Gliquidone Segment by Company
Boehringer Ingelheim
Dexa Medica
Menarini Belgium
CR Double-Crane
Jinheng Pharma
Vanguard Pharma
Yiling Pharma
TIPR
Gliquidone Segment by Type
Glequinone Tablets
Glequinone Capsule
Glequinone Sustained Release Tablets
Others
Gliquidone Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Gliquidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gliquidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Gliquidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Gliquidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gliquidone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glequinone Tablets
- Glequinone Capsule
- Glequinone Sustained Release Tablets
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Boehringer Ingelheim
- Dexa Medica
- Menarini Belgium
- CR Double-Crane
- Jinheng Pharma
- Vanguard Pharma
- Yiling Pharma
- TIPR
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Gliquidone Market by Type
- 1.2.1 Global Gliquidone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Glequinone Tablets
- 1.2.3 Glequinone Capsule
- 1.2.4 Glequinone Sustained Release Tablets
- 1.2.5 Others
- 1.3 Gliquidone Market by Application
- 1.3.1 Global Gliquidone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pharmacies
- 1.3.3 Online Pharmacies
- 1.3.4 Retail Pharmacies
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gliquidone Market Dynamics
- 2.1 Gliquidone Industry Trends
- 2.2 Gliquidone Industry Drivers
- 2.3 Gliquidone Industry Opportunities and Challenges
- 2.4 Gliquidone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Gliquidone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Gliquidone Revenue by Region
- 3.2.1 Global Gliquidone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Gliquidone Revenue by Region (2021-2026)
- 3.2.3 Global Gliquidone Revenue by Region (2027-2032)
- 3.2.4 Global Gliquidone Revenue Market Share by Region (2021-2032)
- 3.3 Global Gliquidone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Gliquidone Sales by Region
- 3.4.1 Global Gliquidone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Gliquidone Sales by Region (2021-2026)
- 3.4.3 Global Gliquidone Sales by Region (2027-2032)
- 3.4.4 Global Gliquidone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Gliquidone Revenue by Manufacturers
- 4.1.1 Global Gliquidone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Gliquidone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Gliquidone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Gliquidone Sales by Manufacturers
- 4.2.1 Global Gliquidone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Gliquidone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Gliquidone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Gliquidone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Gliquidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Gliquidone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Gliquidone Manufacturers, Product Type & Application
- 4.7 Global Gliquidone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Gliquidone Market CR5 and HHI
- 4.8.2 2025 Gliquidone Tier 1, Tier 2, and Tier 3
5 Gliquidone Market by Type
- 5.1 Global Gliquidone Revenue by Type
- 5.1.1 Global Gliquidone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Gliquidone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Gliquidone Revenue Market Share by Type (2021-2032)
- 5.2 Global Gliquidone Sales by Type
- 5.2.1 Global Gliquidone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Gliquidone Sales by Type (2021-2032) & (kg)
- 5.2.3 Global Gliquidone Sales Market Share by Type (2021-2032)
- 5.3 Global Gliquidone Price by Type
6 Gliquidone Market by Application
- 6.1 Global Gliquidone Revenue by Application
- 6.1.1 Global Gliquidone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Gliquidone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Gliquidone Revenue Market Share by Application (2021-2032)
- 6.2 Global Gliquidone Sales by Application
- 6.2.1 Global Gliquidone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Gliquidone Sales by Application (2021-2032) & (kg)
- 6.2.3 Global Gliquidone Sales Market Share by Application (2021-2032)
- 6.3 Global Gliquidone Price by Application
7 Company Profiles
- 7.1 Boehringer Ingelheim
- 7.1.1 Boehringer Ingelheim Company Information
- 7.1.2 Boehringer Ingelheim Business Overview
- 7.1.3 Boehringer Ingelheim Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Boehringer Ingelheim Gliquidone Product Portfolio
- 7.1.5 Boehringer Ingelheim Recent Developments
- 7.2 Dexa Medica
- 7.2.1 Dexa Medica Company Information
- 7.2.2 Dexa Medica Business Overview
- 7.2.3 Dexa Medica Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Dexa Medica Gliquidone Product Portfolio
- 7.2.5 Dexa Medica Recent Developments
- 7.3 Menarini Belgium
- 7.3.1 Menarini Belgium Company Information
- 7.3.2 Menarini Belgium Business Overview
- 7.3.3 Menarini Belgium Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Menarini Belgium Gliquidone Product Portfolio
- 7.3.5 Menarini Belgium Recent Developments
- 7.4 CR Double-Crane
- 7.4.1 CR Double-Crane Company Information
- 7.4.2 CR Double-Crane Business Overview
- 7.4.3 CR Double-Crane Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 CR Double-Crane Gliquidone Product Portfolio
- 7.4.5 CR Double-Crane Recent Developments
- 7.5 Jinheng Pharma
- 7.5.1 Jinheng Pharma Company Information
- 7.5.2 Jinheng Pharma Business Overview
- 7.5.3 Jinheng Pharma Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Jinheng Pharma Gliquidone Product Portfolio
- 7.5.5 Jinheng Pharma Recent Developments
- 7.6 Vanguard Pharma
- 7.6.1 Vanguard Pharma Company Information
- 7.6.2 Vanguard Pharma Business Overview
- 7.6.3 Vanguard Pharma Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Vanguard Pharma Gliquidone Product Portfolio
- 7.6.5 Vanguard Pharma Recent Developments
- 7.7 Yiling Pharma
- 7.7.1 Yiling Pharma Company Information
- 7.7.2 Yiling Pharma Business Overview
- 7.7.3 Yiling Pharma Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Yiling Pharma Gliquidone Product Portfolio
- 7.7.5 Yiling Pharma Recent Developments
- 7.8 TIPR
- 7.8.1 TIPR Company Information
- 7.8.2 TIPR Business Overview
- 7.8.3 TIPR Gliquidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 TIPR Gliquidone Product Portfolio
- 7.8.5 TIPR Recent Developments
8 North America
- 8.1 North America Gliquidone Market Size by Type
- 8.1.1 North America Gliquidone Revenue by Type (2021-2032)
- 8.1.2 North America Gliquidone Sales by Type (2021-2032)
- 8.1.3 North America Gliquidone Price by Type (2021-2032)
- 8.2 North America Gliquidone Market Size by Application
- 8.2.1 North America Gliquidone Revenue by Application (2021-2032)
- 8.2.2 North America Gliquidone Sales by Application (2021-2032)
- 8.2.3 North America Gliquidone Price by Application (2021-2032)
- 8.3 North America Gliquidone Market Size by Country
- 8.3.1 North America Gliquidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Gliquidone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Gliquidone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Gliquidone Market Size by Type
- 9.1.1 Europe Gliquidone Revenue by Type (2021-2032)
- 9.1.2 Europe Gliquidone Sales by Type (2021-2032)
- 9.1.3 Europe Gliquidone Price by Type (2021-2032)
- 9.2 Europe Gliquidone Market Size by Application
- 9.2.1 Europe Gliquidone Revenue by Application (2021-2032)
- 9.2.2 Europe Gliquidone Sales by Application (2021-2032)
- 9.2.3 Europe Gliquidone Price by Application (2021-2032)
- 9.3 Europe Gliquidone Market Size by Country
- 9.3.1 Europe Gliquidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Gliquidone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Gliquidone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Gliquidone Market Size by Type
- 10.1.1 China Gliquidone Revenue by Type (2021-2032)
- 10.1.2 China Gliquidone Sales by Type (2021-2032)
- 10.1.3 China Gliquidone Price by Type (2021-2032)
- 10.2 China Gliquidone Market Size by Application
- 10.2.1 China Gliquidone Revenue by Application (2021-2032)
- 10.2.2 China Gliquidone Sales by Application (2021-2032)
- 10.2.3 China Gliquidone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Gliquidone Market Size by Type
- 11.1.1 Asia Gliquidone Revenue by Type (2021-2032)
- 11.1.2 Asia Gliquidone Sales by Type (2021-2032)
- 11.1.3 Asia Gliquidone Price by Type (2021-2032)
- 11.2 Asia Gliquidone Market Size by Application
- 11.2.1 Asia Gliquidone Revenue by Application (2021-2032)
- 11.2.2 Asia Gliquidone Sales by Application (2021-2032)
- 11.2.3 Asia Gliquidone Price by Application (2021-2032)
- 11.3 Asia Gliquidone Market Size by Country
- 11.3.1 Asia Gliquidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Gliquidone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Gliquidone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Gliquidone Market Size by Type
- 12.1.1 SAMEA Gliquidone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Gliquidone Sales by Type (2021-2032)
- 12.1.3 SAMEA Gliquidone Price by Type (2021-2032)
- 12.2 SAMEA Gliquidone Market Size by Application
- 12.2.1 SAMEA Gliquidone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Gliquidone Sales by Application (2021-2032)
- 12.2.3 SAMEA Gliquidone Price by Application (2021-2032)
- 12.3 SAMEA Gliquidone Market Size by Country
- 12.3.1 SAMEA Gliquidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Gliquidone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Gliquidone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Gliquidone Value Chain Analysis
- 13.1.1 Gliquidone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Gliquidone Production Mode & Process
- 13.2 Gliquidone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Gliquidone Distributors
- 13.2.3 Gliquidone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst